Identification and characterization of Toxoplasma gondii aspartic protease 1 as a novel vaccine candidate against toxoplasmosis
Open Access
- 14 June 2013
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 6 (1) , 1-13
Abstract
Toxoplasma gondii is an obligate intracellular parasite that can pose a serious threat to human health by causing toxoplasmosis. There are no drugs that target the chronic cyst stage of this infection; therefore, development of an effective vaccine would be an important advance. Aspartic proteases play essential roles in the T. gondii lifecycle. The parasite has four aspartic protease encoding genes, which are called toxomepsin 1, 2, 3 and 5 (TgASP1, 2, 3 and 5, respectively). Bioinformatics approaches have enabled us to identify several promising linear-B cell epitopes and potential Th-cell epitopes on TgASP1, thus supporting its potential as a DNA vaccine against toxoplasmosis. We expressed TgASP1 in Escherichia coli and used the purified protein to immunize BALB/c mice. The antibodies obtained were used to determine where TgASP1 was localized in the parasite. We also made a TgASP1 DNA vaccine construct and evaluated it for the level of protection conferred to mice against infection with the virulent RH strain of T. gondii. TgASP1 appears to be a membrane protein located primarily at the tip of the T. gondii tachyzoite. Investigation of its potential as a DNA vaccine showed that it elicited strong humoral and cellular immune responses in mice, and that these responses were mediated by Th-1 cells. Mice immunized with the vaccine had greater levels of protection against mortality following challenge with T. gondii RH tachyzoites than did those immunized with PBS or the empty vector control. TgASP1 is a novel candidate DNA vaccine that merits further investigation.Keywords
This publication has 48 references indexed in Scilit:
- Induction of Protective Immune Responses by a Multiantigenic DNA Vaccine Encoding GRA7 and ROP1 of Toxoplasma gondiiClinical and Vaccine Immunology, 2012
- Targeted Disruption of Toxoplasma gondii Serine Protease Inhibitor 1 Increases Bradyzoite Cyst Formation In Vitro and Parasite Tissue Burden in MiceInfection and Immunity, 2012
- Suppression of Dendritic Cell-mediated Responses by Genes in Calcium and Cysteine Protease Pathways during Mycobacterium tuberculosis InfectionJournal of Biological Chemistry, 2012
- Seroprevalence of Toxoplasma gondii infection in household and stray cats in Lanzhou, northwest ChinaParasites & Vectors, 2011
- Tools and collaborative environments for bioinformatics researchBriefings in Bioinformatics, 2011
- Toxoplasma gondii infection in humans in ChinaParasites & Vectors, 2011
- Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemesMolecular and Biochemical Parasitology, 2011
- Molecular characterisation of a novel family of cysteine-rich proteins of Toxoplasma gondii and ultrastructural evidence of oocyst wall localisationInternational Journal for Parasitology, 2010
- Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in miceBMC Biotechnology, 2010
- Plasmodium Food Vacuole Plasmepsins Are Activated by FalcipainsJournal of Biological Chemistry, 2008